首页 | 本学科首页   官方微博 | 高级检索  
     

川芎嗪治疗椎-基底动脉供血不足性眩晕的临床分析
引用本文:魏伟立,许晓红,林妙芬,谢伟基,郑文平. 川芎嗪治疗椎-基底动脉供血不足性眩晕的临床分析[J]. 中国热带医学, 2006, 6(8): 1451-1452
作者姓名:魏伟立  许晓红  林妙芬  谢伟基  郑文平
作者单位:汕头大学医学院第二附属医院内科,广东,汕头,515041
摘    要:目的 探讨大剂量川芎嗪注射液治疗椎-基底动脉供血不足性眩晕(VBIV)的临床疗效。方法选择经彩色多普勒血流诊断仪确诊的VBIV患者42例,随机分为两组,治疗组22例给予川芎嗪200mg静脉滴注,对照组20例采用血管扩张剂复方丹参注射液16ml静脉滴注,每日1次,2wk为1疗程,两个疗程后评价疗效。结果治疗组与对照组有效率分别为86.36%和55.00%,两组比较差异有显著性(P〈0.05)。结论大剂量川芎嗪治疗椎-基底动脉供血不足性眩晕具有较好的疗效,值得临床推广应用。

关 键 词:椎-基底动脉供血不足  川芎嗪  眩晕
文章编号:1009-9727(2006)08-1451-02
收稿时间:2006-05-19
修稿时间:2006-05-19

Treatment of vertebro-basilar ischemic vertigo with ligustrazine
WEI Wei - li, XU Xiao - hong, LIN Miao - fen, et al. Treatment of vertebro-basilar ischemic vertigo with ligustrazine[J]. China Tropical Medicine, 2006, 6(8): 1451-1452
Authors:WEI Wei - li   XU Xiao - hong   LIN Miao - fen   et al
Affiliation:Department of Internal Medicine, The Second Affiliated Hospital of Shantou University Medical College, Shantou 515041, Guangdong, P. R. China
Abstract:Objective To explore the clinical efficacy of Large dosage of ligustrazine on vertebro-basilar ischemic vertigo(VBIV). Methods 42 VBIV cases diagnosised by color doppler were randomly divided into two groups,the treatmetn group consisted of 22 cases treated with ligustrazine injections and the control group consisted of 20 cases treated with vasodilator salviac miltiorrhizae Co injectious,one a day for two weeks.The curative effect were compared. Results The total effective rate in the treatment group was 86.36% aud 55.00% in control group,showing significant difference(P<0.05). Conclusion Large dosage of Ligustraziue injections is effective for treatment of VBIV and it is worthshile to be popularized for clinical use.
Keywords:Vertebro - basilar Ischemia   Ligustrazine    Vertigo
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号